Please sign in to follow a disease.
Sweat gland disorder
MONDO:0006615A disease involving the sweat gland.
Also known as: disease of sweat gland, disease or disorder of sweat gland, disorder of sweat gland, sweat gland disease, sweat gland disease or disorder, disease of sweat glands, disorder of sweat glands
148 clinical trials for this condition and its sub-types, 7 tagged with Sweat gland disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Sweat gland disorder
-
Apocrine sweat gland disorder 0 trials · 138 incl. sub-types
3 sub-types
- Hidradenitis 21 trials · 135 incl. sub-types Sub-types →
- Apocrine sweat gland neoplasm 1 trial · 3 incl. sub-types Sub-types →
- Chromhidrosis 0 trials
-
Miliaria 7 trials
8 sub-types
- Infantile miliaria 0 trials
- Miliaria alba 0 trials
- Miliaria crystallina 0 trials
- Miliaria papulosa 0 trials
- Miliaria profunda 0 trials
- Miliaria pustulosa 0 trials
- Miliaria rubra 0 trials
- Miliaria vesiculosa 0 trials
-
Sweat gland neoplasm 0 trials · 3 incl. sub-types
6 sub-types
- Apocrine sweat gland neoplasm 1 trial · 3 incl. sub-types Sub-types →
- Sweat gland cancer 1 trial · 2 incl. sub-types Sub-types →
- Eccrine sweat gland neoplasm 0 trials · 1 incl. sub-types Sub-types →
- Syringoma 0 trials · 1 incl. sub-types Sub-types →
- Benign neoplasm of sweat gland 0 trials Sub-types →
- Sweat gland adenoma 0 trials Sub-types →
-
Dyshidrosis 2 trials
-
Anhidrosis 1 trial
2 sub-types
-
Fox-Fordyce disease 0 trials
Most studied deeper sub-types
-
New antibody drug aims to calm painful skin condition
Disease control OngoingThis Phase 2 trial tests tibulizumab, a dual-action antibody, in 225 adults with hidradenitis suppurativa (HS), a chronic skin condition causing painful abscesses. Participants first receive either the drug or a placebo for 16 weeks, then everyone gets the drug for another 16 wee…
Phase 2 • Sponsor: Zura Bio Inc • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for HS sufferers: Long-Term drug trial expands
Disease control By invitation onlyThis study looks at the long-term safety and effectiveness of a drug called sonelokimab for people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. About 835 adults and teens who completed an earlier sonelokimab study will receive the drug for an e…
Phase 3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug trial aims to help teens with painful skin condition
Disease control OngoingThis study tests a drug called sonelokimab in 35 teenagers aged 12 to 17 with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition that causes painful lumps. The main goals are to see how the drug moves through the body and whether it is safe. Researchers wi…
Phase 3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC